Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Iovance Biotherapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 219
- −10 vs. Q1 2023
- Shares held
- 204.0M
- −1.27M (−0.6%) vs. Q1 2023
- Total value
- $1.44B
- +$181.3M (+14.4%) vs. Q1 2023
- New holders
- 29
- 92 more added
- Sold out
- 39
- 65 more reduced
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IOVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 293 | $1.19B |
| Q1 2026 | 286 | $943.8M |
| Q4 2025 | 263 | $713.7M |
| Q3 2025 | 253 | $462.3M |
| Q2 2025 | 255 | $379.3M |
| Q1 2025 | 303 | $798.9M |
| Q4 2024 | 302 | $1.79B |
| Q3 2024 | 286 | $2.21B |
| Q2 2024 | 295 | $1.86B |
| Q1 2024 | 273 | $3.22B |
| Q4 2023 | 236 | $1.69B |
| Q3 2023 | 228 | $970.0M |
| Q2 2023 | 219 | $1.44B |
| Q1 2023 | 230 | $1.25B |
| Q4 2022 | 218 | $1.11B |
| Q3 2022 | 242 | $1.48B |
| Q2 2022 | 238 | $1.75B |
| Q1 2022 | 248 | $2.60B |
| Q4 2021 | 246 | $2.96B |
| Q3 2021 | 244 | $3.88B |
| Q2 2021 | 234 | $4.22B |
| Q1 2021 | 252 | $4.98B |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Iovance Biotherapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Credit Suisse AG | 2,794,124 | $19.7M | 0.02% | +97,282+3.6% | Added |
| MPM Oncology Impact Management LP | 2,950,118 | $20.8M | 4.18% | +335,141+12.8% | Added |
| Deutsche Bank AG | 3,311,980 | $23.3M | 0.01% | +2,387,330+258.2% | Added |
| Morgan Stanley | 3,497,608 | $24.6M | 0.00% | −4,195,083−54.5% | Reduced |
| Goldman Sachs Group Inc | 3,535,267 | $24.9M | 0.01% | −397,717−10.1% | Reduced |
| Millennium Management LLC | 3,580,668 | $25.2M | 0.03% | +168,069+4.9% | Added |
| Price T Rowe Associates Inc | 3,663,373 | $25.8M | 0.00% | −92,495−2.5% | Reduced |
| Boxer Capital, LLC | 3,705,133 | $26.1M | 1.21% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 4,138,362 | $29.1M | 0.00% | +1,098,929+36.2% | Added |
| Artisan Partners Limited Partnership | 4,426,741 | $31.2M | 0.05% | +858,035+24.0% | Added |
| OrbiMed Advisors LLC | 4,707,458 | $33.1M | 0.64% | 00.0% | Unchanged |
| Pictet Asset Management SA | 5,175,080 | $36.4M | 0.04% | +4,210,788+436.7% | Added |
| Avoro Capital Advisors LLC | 6,700,000 | $47.2M | 0.64% | −320,000−4.6% | Reduced |
| Point72 Asset Management, L.P. | 7,786,985 | $54.8M | 0.19% | −1,013,074−11.5% | Reduced |
| MHR Fund Management LLC | 11,997,103 | $84.5M | 11.88% | 00.0% | Unchanged |
| State Street Corp | 13,565,798 | $95.5M | 0.01% | −167,235−1.2% | Reduced |
| Perceptive Advisors LLC | 14,036,410 | $98.8M | 2.87% | −1,303,325−8.5% | Reduced |
| BlackRock Inc. | 17,001,791 | $119.7M | 0.00% | +4,545,129+36.5% | Added |
| Vanguard Group Inc | 20,395,388 | $143.6M | 0.00% | +6,855,259+50.6% | Added |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −1,831,607−100.0% | Sold out |
| Kynam Capital Management, LP | 0 | $0 | 0.00% | −1,800,000−100.0% | Sold out |
| Healthcare of Ontario Pension Plan Trust Fund | 0 | $0 | 0.00% | −1,127,900−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −945,516−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −651,664−100.0% | Sold out |
| Lombard Odier Asset Management (Switzerland) SA | 0 | $0 | 0.00% | −530,452−100.0% | Sold out |
| Peregrine Capital Management LLC | 0 | $0 | 0.00% | −301,068−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −280,846−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −267,997−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −216,782−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −166,172−100.0% | Sold out |
| Jupiter Asset Management Ltd | 0 | $0 | 0.00% | −164,360−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −153,639−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −143,013−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −112,238−100.0% | Sold out |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −105,000−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −84,325−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −82,830−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −80,455−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −60,571−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −55,835−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −46,435−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −41,632−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −38,528−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −34,100−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −26,299−100.0% | Sold out |
| Winton Group Ltd | 0 | $0 | 0.00% | −18,929−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −13,605−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −11,200−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −10,940−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −10,932−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| Systematic Financial Management LP | 0 | $0 | 0.00% | −7,809−100.0% | Sold out |
| Advisors Asset Management, Inc. | 0 | $0 | 0.00% | −3,941−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −555−100.0% | Sold out |
| Red Tortoise LLC | 0 | $0 | 0.00% | −195−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Fairfield Financial Advisors, LTD | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Kula Investments, LLC | – | – | – | – | Not filed |